![](/images/png/glyphicons-368-expand.png)
![](/images/png/glyphicons-791-one-day.png)
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
[ Wed, Sep 13th 2017
] - WOPRAI
![](/images/png/glyphicons-791-one-day.png)
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
[ Tue, Sep 12th 2017
] - WOPRAI
![](/images/png/glyphicons-791-one-day.png)
[ Mon, Sep 11th 2017
] - WOPRAI
Tim Chiang Upgraded (TEVA) to Strong Buy and Held Target at $24 on, Sep 11th, 2017
Tim Chiang of BTIG, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Strong Buy and Held Target at $24 on, Sep 11th, 2017.
Tim has made no other calls on TEVA in the last 4 months.
There are 10 other peers that have a rating on TEVA. Out of the 10 peers that are also analyzing TEVA, 7 agree with Tim's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Liav Abraham of "Citigroup" Downgraded from Strong Buy to Hold on, Wednesday, August 16th, 2017
- Douglas Tsao of "Barclays" Maintained at Hold with Decreased Target to $23 on, Monday, August 7th, 2017
- Tyler Van Buren of "Cowen & Co." Downgraded from Buy to Hold on, Friday, August 4th, 2017
- Aaron Gal of "Bernstein" Downgraded from Buy to Hold on, Friday, August 4th, 2017
- Derek Archila of "Oppenheimer" Downgraded from Buy to Hold on, Thursday, August 3rd, 2017
- Irina Rivkind Koffler of "Mizuho" Upgraded from Sell to Hold on, Friday, June 16th, 2017
- Louise Chen of "Cantor Fitzgerald" Initiated at Hold and Held Target at $31 on, Thursday, June 15th, 2017
These are the ratings of the 3 analyists that currently disagree with Tim
- Vamil Divan of "JMP Securities" Maintained at Sell with Increased Target to $14 on, Wednesday, September 6th, 2017
- David Risinger of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $16 on, Monday, August 7th, 2017
- Randall Stanicky of "RBC Capital" Downgraded from Buy to Sell on, Friday, August 4th, 2017